Amarin Corp Plc (AMRN)

[rosemountbomber]

Enjoying the discussion between you and Kiwi. At $1.15, as dismal as the situation looks, the risk/reward equation seems to favor hanging in there, as all the negatives seem to be in and potential positives hopefully soon to come to fruition.

There are two points that bother me when thinking about a potential BO. Someone here posted a year or two ago, how the vast majority of buyouts occur around (either before or after phase III results) but many times before drug approval and product rollout. In our case, that time is long past. I worry that we have demonstrated V's poor uptake. Of course in the U.S. that can be primarily blamed on Generics entering the fray (and the subsequent need for Amarin to shut down advertising to conserve cash and not feed the Generics). The other thing is time. Exclusivity is wasting away in the EU. So, I am still hopeful that some deal materializes, but for those reasons I mentioned I do have grandiose expectations of a high valuation. Now, unless we get some additional data, either related to CVD or possibly AD.